Synthetic host defense peptide IDR-1002 reduces inflammation in Pseudomonas aeruginosa lung infection
出版年份 2017 全文链接
标题
Synthetic host defense peptide IDR-1002 reduces inflammation in Pseudomonas aeruginosa lung infection
作者
关键词
Pseudomonas aeruginosa, Inflammation, Cytokines, Toxicity, Chemokines, Cytotoxicity, Analysis of variance, Macrophages
出版物
PLoS One
Volume 12, Issue 11, Pages e0187565
出版商
Public Library of Science (PLoS)
发表日期
2017-11-07
DOI
10.1371/journal.pone.0187565
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- A short D-enantiomeric antimicrobial peptide with potent immunomodulatory and antibiofilm activity against multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii
- (2017) Mohamed F. Mohamed et al. Scientific Reports
- In vitro and in vivo evaluation of BMAP-derived peptides for the treatment of cystic fibrosis-related pulmonary infections
- (2016) Mario Mardirossian et al. AMINO ACIDS
- Peptide IDR-1002 Inhibits NF-κB Nuclear Translocation by Inhibition of IκBα Degradation and Activates p38/ERK1/2–MSK1-Dependent CREB Phosphorylation in Macrophages Stimulated with Lipopolysaccharide
- (2016) Alejandro Huante-Mendoza et al. Frontiers in Immunology
- Immunomodulatory Peptide IDR-1018 Decreases Implant Infection and Preserves Osseointegration
- (2015) Hyonmin Choe et al. CLINICAL ORTHOPAEDICS AND RELATED RESEARCH
- A Broad-Spectrum Antibiofilm Peptide Enhances Antibiotic Action against Bacterial Biofilms
- (2014) Fany Reffuveille et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Immune modulation by multifaceted cationic host defense (antimicrobial) peptides
- (2013) Ashley L Hilchie et al. Nature Chemical Biology
- Ability of Innate Defence Regulator Peptides IDR-1002, IDR-HH2 and IDR-1018 to Protect against Mycobacterium tuberculosis Infections in Animal Models
- (2013) Bruno Rivas-Santiago et al. PLoS One
- Pseudomonas aeruginosa: new insights into pathogenesis and host defenses
- (2013) Shaan L. Gellatly et al. Pathogens and Disease
- A comprehensive summary of LL-37, the factotum human cathelicidin peptide
- (2012) Dieter Vandamme et al. CELLULAR IMMUNOLOGY
- Innate Defense Regulator Peptide 1018 in Wound Healing and Wound Infection
- (2012) Lars Steinstraesser et al. PLoS One
- Effective Adjunctive Therapy by an Innate Defense Regulatory Peptide in a Preclinical Model of Severe Malaria
- (2012) A. H. Achtman et al. Science Translational Medicine
- The Human Cathelicidin LL-37 Preferentially Promotes Apoptosis of Infected Airway Epithelium
- (2010) Peter G. Barlow et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Structural Studies of a Peptide with Immune Modulating and Direct Antimicrobial Activity
- (2010) Michal Wieczorek et al. CHEMISTRY & BIOLOGY
- Synthetic Cationic Peptide IDR-1002 Provides Protection against Bacterial Infections through Chemokine Induction and Enhanced Leukocyte Recruitment
- (2010) Anastasia Nijnik et al. JOURNAL OF IMMUNOLOGY
- Efficacy of Aerosol MP-376, a Levofloxacin Inhalation Solution, in Models of Mouse Lung Infection Due to Pseudomonas aeruginosa
- (2009) M. Sabet et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Urinary tract infections caused by Pseudomonas aeruginosa: A minireview
- (2009) Rahul Mittal et al. Journal of Infection and Public Health
- Newly introduced genomic prophage islands are critical determinants of in vivo competitiveness in the Liverpool Epidemic Strain of Pseudomonas aeruginosa
- (2008) C. Winstanley et al. GENOME RESEARCH
- Immune Response of Human Propagated γδ-T-Cells to Neuroblastoma Recommend the Vδ1+ Subset for γδ-T-cell–based Immunotherapy
- (2008) Karin Schilbach et al. JOURNAL OF IMMUNOTHERAPY
- Animal models of chronic lung infection with Pseudomonas aeruginosa: useful tools for cystic fibrosis studies
- (2008) I Kukavica-Ibrulj et al. LABORATORY ANIMALS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started